Evidence map›Paper›PMID 40559206›Full record

ArticleThyroid : official journal of the American Thyroid Association2025

Characterizing Thyroid Hormone Replacement, Baseline Thyrotropin, and Survival in Immune Checkpoint Inhibitor-Associated Thyroid Dysfunction.

Duaa Abdallah, Jake Johnson, Fang Qiu, Whitney Goldner, Apar Kishor Ganti, Anupam Kotwal

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Thyroid : official journal of the American Thyroid Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Duaa AbdallahDepartment of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Jake JohnsonDepartment of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Fang QiuDepartment of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Whitney GoldnerDepartment of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Apar Kishor GantiDepartment of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Anupam KotwalDepartment of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.ORCID 0000-0002-4500-8546

Funding

Tracking and Evaluation CoreU54GM115458 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI RIZZO, MATTHEW · 2016 to 2025
$42.8M
NIGMS NIH HHS U54 GM115458
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hormone Replacement TherapyHypothyroidismImmune Checkpoint InhibitorsNeoplasmsThyroid DiseasesThyrotropinAdultAgedFemaleHumansMaleMiddle AgedRetrospective StudiesThyroxineImmune Checkpoint InhibitorsThyrotropinThyroxinehypothyroidismimmune-related adverse eventsimmunotherapythyroiditisthyrotoxicosis

Identifiers

PMID40559206
PMCPMC12281114

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.